• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Daily Swing Trade Archive
    • Income Seeker
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Indexes Hold Onto Week's Gains

Stocks might have been expected to sell off ahead of a three-day weekend and amid trade tensions between the U.S. and its largest trading partners, but they didn't.
By JAMES "REV SHARK" DEPORRE
Aug 31, 2018 | 04:33 PM EDT
Stocks quotes in this article: HTGM, AAPL

After a big week, some selling in front of the long weekend would not only be logical but healthy.

However, even the failure of a trade deal with Canada couldn't put a dent in this market.

The indices didn't' do much but they definitely did fall apart. They even managed to spike up on the news about the failure of the Canadian trade deal because new talks are going to start right back up next Wednesday.

It has been one-way action most of the week with just some minor selling after things became extended on Wednesday. What has helped the mood is that trading in individual stocks has been quite good.

There was plenty of strength is speculative names especially in the biotechnology stock. My stock of the week, HTG Molecular Diagnostics (HTGM) managed a gain of 32% this week.

FAANG names have helped quite a bit. Apple (AAPL) was up over 5% this week which has a significant impact on the indices. But this has not been a narrow rally this time. Breadth was better today with around 4000 gainers to 3000 decliners and the new highs continue to pile up.

There is no question that the trend is strong. Seasonality is probably hurting volume but that doesn't seem to matter. The indices are extended as are many stocks, so you have to wonder when we will see some pullbacks but the worst thing you can do Is to keep anticipating a top.

Have a great long weekend. I'll see you on Tuesday.

Apple is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells AAPL? Learn more now.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long HTGM.

TAGS: Investing | U.S. Equity | Healthcare | Stocks

More from Healthcare

CVS' Massive M&A Moves Spark Skepticism on the Stock

Kevin Curran
Feb 20, 2019 4:10 PM EST

CVS' spending spree has developed a deep debt issue for the company.

Chart of the Day: Is CVS Stock Too Cheap to Ignore?

Kevin Curran
Feb 20, 2019 2:06 PM EST

Is CVS open to those seeking value?

Trump Administration Is No Friend to Pharmacy Benefit Managers Like CVS

Kevin Curran
Feb 20, 2019 12:09 PM EST

Pharmacy Benefit Managers (PBMs) are in for some problems if proposed regulation is given approval.

Anthem Is Pointed Up but Let's Tighten Our Stop Protection

Bruce Kamich
Feb 20, 2019 10:19 AM EST

Sticking to the charts and technical indicators.

3 Small Biotechs to Watch as Earnings Season Winds Down

Bret Jensen
Feb 20, 2019 9:12 AM EST

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:48 AM EST BOB LANG

    Making a Case for Microsoft and Snap

    Mr Softy has long been a laggard and late to the p...
  • 11:27 AM EST BOB LANG

    Added Some Dexcom

    This company reports tonight, the chart/technicals...
  • 10:08 AM EST KEVIN CURRAN

    Nike Options Action Spikes

    Nike options volume is surging as speculators pi...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login